Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX) announced that CEO Barbara Weber, M.D. will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference on Wednesday, November 19, 2025, 4:30–4:55 PM GMT / 11:30–11:55 AM ET. The session will be available live via webcast under the "Events & Presentations" tab on the company's Investors page. A replay will be archived on the company's website for 90 days after the presentation.

News Market Reaction

-8.47%

13 alerts

-8.47% News Effect

-2.3% Trough in 16 min

-$97M Valuation Impact

$1.05B Market Cap

0.8x Rel. Volume

On the day this news was published, TNGX declined 8.47%, reflecting a notable negative market reaction. Argus tracked a trough of -2.3% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $97M from the company's valuation, bringing the market cap to $1.05B at that time.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference on Wednesday, November 19 at 4:30-4:55 PM GMT / 11:30-11:55am ET.

The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.

Investors and Media:

Elizabeth Hickin
IR@tangotx.com
media@tangotx.com

FAQ

When will Tango Therapeutics (TNGX) present at the Jefferies Global Healthcare Conference on November 19, 2025?

Tango's CEO will speak on November 19, 2025 from 4:30–4:55 PM GMT / 11:30–11:55 AM ET.

How can investors watch Tango Therapeutics (TNGX) live at the Jefferies conference?

Watch the live webcast under the "Events & Presentations" tab on the company's Investors webpage on the day of the event.

Will there be a replay of Tango Therapeutics (TNGX) presentation from the Jefferies conference?

Yes. A replay will be archived on the company's website for 90 days following the presentation.

Who is representing Tango Therapeutics (TNGX) at the 2025 Jefferies Global Healthcare Conference?

Barbara Weber, M.D., President and Chief Executive Officer, will participate in the fireside chat.

What topics will Tango Therapeutics (TNGX) cover at the Jefferies Global Healthcare Conference?

The announcement confirms a fireside chat by the CEO but does not list specific topics.

Where on the Tango Therapeutics (TNGX) site is the Jefferies conference webcast posted?

The webcast will be posted under the "Events & Presentations" tab on the company's Investors page.